NASDAQ: OFIX

Orthofix Medical Inc.

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Orthofix Medical Inc.  (NASDAQ: OFIX) resulting from allegations that Orthofix may have issued materially misleading business information to the investing public.

If you purchased Orthofix securities and would like to join the prospective action, please click “Join This Class Action.”

If you purchased Orthofix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of investigation:

On September 12, 2023, Orthofix issued a press release announcing leadership changes, including the appointment of an Interim Chief Executive Officer, Interim Chief Financial Officer, and Interim Chief Legal Officer. The press release stated that “[t]he appointments are effective immediately and follow the unanimous decision by the Board’s independent directors to terminate for cause Keith Valentine, John Bostjancic and Patrick Keran from those respective roles. The Board also requested that Mr. Valentine resign from the Board.” Orthofix further stated that “[t]he Board’s decision follows an investigation conducted by independent outside legal counsel and directed and overseen by the Company’s independent directors. As a result of the investigation, the Board determined that each of these executives engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company’s values and culture.”

On this news, Orthofix’s stock price fell $5.62 per share, or 30.17%, to close at $13.01 per share on September 12, 2023.

关注我们:
公司名称: Orthofix Medical Inc.
股票代号: OFIX
集体诉讼期: N/A
法院: N/A

为何选择罗森律师事务所?

自 2013 年以来,罗森律师事务所每年都是代表投资者成功提起证券集体诉讼的前四大律所之一。仅 2019 年,本律所就为投资者追回 4.38 亿美元资金。

投资者应仔细鉴别和遴选在引领证券集体诉讼方面有多年成功经验的的律师。通常,其他律所会发布关于集体诉讼的新闻稿,但却没有类似的经验或资源。

机构股东服务公司按 2017 年证券集体诉讼索赔数量,罗森律师事务所列为第一名。

罗森律师事务所为全球投资者提供代理服务。我们的使命是提起证券欺诈集体诉讼以及保护股东的权利。

滚动至顶部